SBIR/STTR Research Award

Cartilage-Cartilage Adhesion by Photopolymerization

Award identifier c18f19a52d99a6f1528e9db659a24dfebb2a9585d76b4ed079ae6fd462979756Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,389,500

Program and phase

SBIR · Phase II

Award year

2005

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Synthasome, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
U7HNMMTVDLN6
Solicitation number
PHS2005-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): We have recently developed a new technology called tissue-initiated photopolymerization, which permits direct covalent integration of a polymer into collagen, that has been shown to mechanically stabilize the hydrogel-cartilage interaction. Furthermore, the technique we have developed, allows in situ hydrogel formation to occur without exogenous photoinitiator, improving biocompatibility. Patent applications covering this technology have been filed. There are several envisoned applications of this technology, and the objective of this program is to develop the first application, to provide a method for annealing of grafted cartilage to the surrounding host articular cartilage. It is anticipated that this will provide a stable implantation of grafts into the articular defect site, and that this will substantially increase long term performance of the implanted material. The overall hypothesis for this program is that articular cartilage can be successfully integrated into the surrounding tissue to repair focal articular defects. The work in the Phase I project was to demonstrate feasibility of the approach, with the goals to achieve adhesion >2 times greater (160 kPa) than that achieved previously, and to not extend cell death beyond what would be expected by cutting cartilage (100-200 um). The adhesion strength achieved was 543 kPa, and cell death was not extended beyond 113 um. We therefore achieved the goals in the Phase I project. The aims of the Phase II project is to optimize the device for articular cartilage, demonstrate effectiveness in a goat model of osteochondral repair, and assess biocompatibility. The successful outcome of this project will allow for submission to the FDA for product clearance (510k) or initiation of a clinical trial.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

10 SBIR/STTR records share this UEI (2004–2012). Reported award amounts total $6,433,466. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Defense

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.